L’anticorps anti-CD4 (Ibalizumab Biosimilar) Monoclonal produit chez le Souris a été validé pour FACS et in vivo. Il convient pour la détection de CD4 (Ibalizumab Biosimilar) dans des échantillons provenant de Humain.
}
Aperçu rapide pour Recombinant CD4 (Ibalizumab Biosimilar) anticorps (ABIN7795119)
Antigène
CD4 (Ibalizumab Biosimilar)
Type d'anticorp
Recombinant Antibody
Reactivité
Humain
Hôte
Souris
Clonalité
Monoclonal
Conjugué
Cet anticorp CD4 (Ibalizumab Biosimilar) est non-conjugé
Application
Flow Cytometry (FACS), In vivo Studies (in vivo)
Classe de qualité
Research Grade
Expression System
Mammalian cells
Fonction
Ibalizumab Biosimilar, Human CD4 Monoclonal Antibody
Attributs du produit
What is ibalizumab biosimilar research grade? Ibalizumab Biosimilar uses the same protein sequences as the therapeutic antibody ibalizumab which is a non-immunosuppressive humanised monoclonal antibody that binds CD4, the primary receptor for HIV, and inhibits HIV from entering cells. It is a post-attachment inhibitor, blocking HIV from binding to the CCR5 and CXCR4 co-receptors after HIV binds to the CD4 receptor on the surface of a CD4 cell. Post-attachment inhibitors are a subclass of HIV drugs called entry inhibitors.